Biotechnology Analysis & Statistics, July 2014 (p5)

Talk to Amrita

+1 718 303 2019

Publishers

All regions

You might be interested in: biotech, biomedical, protein, more »

121-150 of about 2 800 reports

Purchase Reports From Reputable Market Research Publishers

CD8+ T cell Activators -Pipeline Insights, 2014

CD8+ T cell Activators -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“CD8+ T cell Activators-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biological Therapy
Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine (C-C Motif) Ligand 2 (CCL2 or Monocyte Chemotactic Protein-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across ...

  • Industries : Biological Therapy
Chemokine Receptor Antagonists -Pipeline Insights, 2014

Chemokine Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Chemokine Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biological Therapy
Cholesterylester Transfer Protein (CETP) Inhibitors -Pipeline Insights, 2014

Cholesterylester Transfer Protein (CETP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Cholesterylester Transfer Protein (CETP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2014

DNA Polymerase Alpha Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DNA Polymerase Alpha Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Genomics
DNA Polymerase Beta Inhibitors -Pipeline Insights, 2014

DNA Polymerase Beta Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DNA Polymerase Beta Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Genomics
DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2014

DNA-Dependent RNA Polymerase Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“DNA-Dependent RNA Polymerase Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Genomics
Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights, 2014

Endothelin Converting Enzyme (ECE) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Endothelin Converting Enzyme (ECE) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biopharmaceutical
Epithelial Cell Adhesion Molecule (EpCAM or CD326) Inhibitors -Pipeline Insights, 2014

Epithelial Cell Adhesion Molecule (EpCAM or CD326) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Epithelial Cell Adhesion Molecule (EpCAM or CD326) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of ...

  • Industries : Biopharmaceutical
Factor IX -Pipeline Insights, 2014

Factor IX -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Factor IX-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish ...

  • Industries : Biopharmaceutical
Factor VIII Inhibitors -Pipeline Insights, 2014

Factor VIII Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Factor VIII Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Farnesyl Protein Transferase (FPTase) Inhibitors -Pipeline Insights, 2014

Farnesyl Protein Transferase (FPTase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Farnesyl Protein Transferase (FPTase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biopharmaceutical
Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

Fibroblast Activation Protein (FAP or Seprase) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Activation Protein (FAP or Seprase) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor (FGF) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor (FGF) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor (FGFR) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
FK506 Binding Protein (FKBP) Inhibitors -Pipeline Insights, 2014

FK506 Binding Protein (FKBP) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“FK506 Binding Protein (FKBP) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
Follicle-Stimulating Hormone Receptor (FSH Receptor or FSHR) Antagonists -Pipeline Insights, 2014

Follicle-Stimulating Hormone Receptor (FSH Receptor or FSHR) Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Follicle-Stimulating Hormone Receptor (FSH Receptor or FSHR) Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism ...

  • Industries : Biopharmaceutical
Factor IX A Inhibitors -Pipeline Insights, 2014

Factor IX A Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Factor IX A Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report ...

  • Industries : Biopharmaceutical
Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor 1 (FGF-1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor 1 (FGF-1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor (FGFR) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor (FGFR) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 1 (FGFR1) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 1 (FGFR1) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 2 (FGFR2) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 3 (FGFR3) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action ...

  • Industries : Biological Therapy
FK506 Binding Protein 12 (FKBP12) Inhibitors -Pipeline Insights, 2014

FK506 Binding Protein 12 (FKBP12) Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“FK506 Binding Protein 12 (FKBP12) Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key ...

  • Industries : Biopharmaceutical
G-CSF Inhibitors -Pipeline Insights, 2014

G-CSF Inhibitors -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“G-CSF Inhibitors-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is ...

  • Industries : Biological Therapy
Glucagon Receptor Agonists -Pipeline Insights, 2014

Glucagon Receptor Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucagon Receptor Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the ...

  • Industries : Biopharmaceutical
Glucagon Receptor Antagonists -Pipeline Insights, 2014

Glucagon Receptor Antagonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucagon Receptor Antagonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of ...

  • Industries : Biopharmaceutical
Glucagon-Like Peptide (GLP) Agonists -Pipeline Insights, 2014

Glucagon-Like Peptide (GLP) Agonists -Pipeline Insights, 2014

  • $ 1 250
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's,“Glucagon-Like Peptide (GLP) Agonists-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective ...

  • Industries : Biopharmaceutical
About 6 500 reports

Download Unlimited Documents from Trusted Public Sources

Medigene - Company Report, August 2014

  • Medigene Significantly Improves Financial Results for the first ...
  • August 2014
    3 pages
  • Therapy  

    Immunotherapy  

  • Germany  

View report >

Protein Supply

August 2014

About 100 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Abbott Laboratories

United States

Life Technologies Corp.

United States

Biogen Idec

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.